These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 17704503)

  • 1. In vitro dissolution study of plutonium in aerosol particles from the Mayak PA: a tool for individualised dose estimates.
    Aladova EE; Romanov SA; Guilmette RA; Khokhryakov VF; Suslova KG
    Radiat Prot Dosimetry; 2007; 127(1-4):60-3. PubMed ID: 17704503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microscopic dose to lung from inhaled alpha emitters in humans.
    Diel J; Belosokhov M; Romanov S; Guilmette R
    Radiat Prot Dosimetry; 2007; 127(1-4):23-6. PubMed ID: 17766263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of initial lung deposit on pulmonary clearance after plutonium oxide inhalation in rat.
    Van der Meeren A; Grillon G; Tourdes F; Rateau S; Le Gall B; Griffiths N
    Radiat Prot Dosimetry; 2007; 127(1-4):50-4. PubMed ID: 17556341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of air monitoring and experimental aerosol data for intake assessment for Mayak plutonium workers.
    Zaytseva YV; Tretyakov FD; Romanov SA; Miller G; Bertelli L; Guilmette RA
    Radiat Prot Dosimetry; 2007; 127(1-4):535-9. PubMed ID: 17848389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased indoor thoron concentrations and implication to inhalation dosimetry.
    Tschiersch J; Li WB; Meisenberg O
    Radiat Prot Dosimetry; 2007; 127(1-4):73-8. PubMed ID: 17634205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further study of the effect of particle size on slow particle clearance from the bronchial tree.
    Smith JR; Bailey MR; Etherington G; Shutt AL; Youngman MJ
    Radiat Prot Dosimetry; 2007; 127(1-4):35-9. PubMed ID: 17827135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updating the ICRP human respiratory tract model.
    Bailey MR; Ansoborlo E; Guilmette RA; Paquet F
    Radiat Prot Dosimetry; 2007; 127(1-4):31-4. PubMed ID: 18192668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of inhomogeneous activity distributions and airway geometry on cellular doses in radon lung dosimetry.
    Szoke I; Balásházy I; Farkas A; Hofmann W
    Radiat Prot Dosimetry; 2007; 127(1-4):68-72. PubMed ID: 17561519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifying the ICRP 66 dosimetry model based on results obtained from Mayak plutonium workers.
    Romanov SA; Guilmette RA; Hahn FF; Nifatov AP; Zaytseva YV; Lyovkina YV
    Radiat Prot Dosimetry; 2003; 105(1-4):85-90. PubMed ID: 14526933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dose estimation from occupational exposure to 239Pu using different modelling approaches.
    Romanov SA; Guilmette RA; Khokhryakov VF; Phipps A; Aladova EE; Bertelli L; Birchall A; Eckerman KF; Khokhryakov VV; Krahenbuhl MP; Leggett RW; Little TT; Miller G; Miller SC; Riddell A; Suslova KG; Vostrotin VV; Zaytseva YV
    Radiat Prot Dosimetry; 2007; 127(1-4):486-90. PubMed ID: 18045798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of 239Pu inhalation doses calculated with ICRP 67 and proposed systemic models.
    Li WB; Oeh U; Paretzke HG
    Radiat Prot Dosimetry; 2007; 127(1-4):148-52. PubMed ID: 17545662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo measurement of Pu dissolution parameters of MOX aerosols and related uncertainties in the values of the dose per unit intake.
    Ramounet-Le Gall B; Rateau G; Abram MC; Grillon G; Ansoborlo E; Bérard P; Delforge J; Fritsch P
    Radiat Prot Dosimetry; 2003; 105(1-4):153-6. PubMed ID: 14526947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of radon lung dosimetry models for the estimation of dose uncertainties.
    Winkler-Heil R; Hofmann W; Marsh J; Birchall A
    Radiat Prot Dosimetry; 2007; 127(1-4):27-30. PubMed ID: 17623685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of plutonium particles in the lungs of Mayak workers.
    Hahn FF; Romanov SA; Guilmette RA; Nifatov AP; Zaytseva YV; Diel JH; Allen SW; Lyovkina YV
    Radiat Prot Dosimetry; 2003; 105(1-4):81-4. PubMed ID: 14526932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation, organ distribution, and excretion kinetics of ²⁴¹Am in Mayak Production Association workers.
    Suslova KG; Sokolova AB; Efimov AV; Miller SC
    Health Phys; 2013 Mar; 104(3):313-24. PubMed ID: 23361427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TENORM aerosols in the Florida phosphate industry--assessment of lung fluid solubility and annual effective dose to workers.
    Kim KP; Wu CY; Birky BK; Bolch WE
    Radiat Prot Dosimetry; 2007; 123(1):41-55. PubMed ID: 16963435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limits of DPUI application associated with the number of particles within actinide aerosols.
    Fritsch P; Raynaud P; Blanchin N; Mièle A
    Radiat Prot Dosimetry; 2007; 127(1-4):553-7. PubMed ID: 17827132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the solubility and size distribution of radioactive aerosols in the uranium processing plant at NRCN.
    Kravchik T; Oved S; Paztal-Levy O; Pelled O; Gonen R; German U; Tshuva A
    Radiat Prot Dosimetry; 2008; 131(4):418-24. PubMed ID: 18676447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MWDS-2016: THE SLOW DISSOLUTION RATE FOR PLUTONIUM NITRATE INTAKES AT THE MAYAK FACILITY.
    Bull RK; Puncher M
    Radiat Prot Dosimetry; 2019 Dec; 185(2):201-207. PubMed ID: 30668839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of the number of alpha hits per target cell: a new parameter to improve risk assessment for cancer induction using ICRP models.
    Fritsch P
    Radiat Prot Dosimetry; 2007; 127(1-4):46-9. PubMed ID: 18227074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.